Lonza, the Swiss Biotech firm that purchased Vacaville’s Genentech plant from Roche in 2024, released a streamlined operating model and invitations to its Annual General Meeting in Basel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback